Sabitlenmiş Tweet

It’s all SMILES as the MPOXVAX AFRICA study in UG reached its sample size. The study is evaluating the safety and immunogenicity of the mpox vaccines among high risk participants. Project partners include @ucddublin @ucbukavu @NIHRresearch @brucekirenga @Lung_Institute #MLIat10



English



















































